Audience & Objectives
High Impact Hepatology: Updates from the Major Liver Meetings
December 5, 2020, Virtual
Physicians, Fellows, Residents, Physician Assistants, Nurses/Nurse Practitioners, and Pharmacists.
At the conclusion of the knowledge-based activity, the learner should be able to:
- Discuss the real world evidence on the natural history of viral hepatitis and chronic liver disease.
- Identify the success and limitations of treatment modalities for autoimmune hepatitis and cholestatic liver disease.
- Discuss the currently available treatment options for patients with NASH.
- Review new concepts in the management of complications of end-stage liver disease, including the management of portal hypertension, hepatic encephalopathy, and hepatocellular carcinoma.